Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma [Phase 2]
Phase 2 study of MT027 allogeneic CAR-T for recurrent glioblastoma (IDH-wildtype) is not yet recruiting, per the trial update.
-
CLINICAL_TRIALS withdrawal · 2026-02-10Clinical Trial Update: HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma [Phase 2]
A Phase 2 trial evaluating HSV G207 with a single radiation dose for children with recurrent high-grade glioma has been withdrawn from Clini…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma [Phase 2]
Phase 2b trial evaluating a combination immunotherapy for newly diagnosed glioblastoma is currently active but not recruiting. Sponsor is Im…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
Completed clinical trial analyzing cell count, viability, and immunogenicity of discarded newly diagnosed glioblastoma tissue or solid tumor…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma [Phase 1]
This clinical trial update describes a Phase 1 study of a neoantigen-based personalized DNA vaccine for newly diagnosed unmethylated gliobla…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT [Phase 1, Phase 2]
Genenta Science is conducting a Phase 1/2 study of Temferon in glioblastoma patients, including those with unmethylated MGMT; the trial is a…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Panitumumab-IRDye800 for fluorescence-guided diagnosis in patients with malignant glioma undergoing su…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1-2 study of ST101 in patients with advanced solid tumors, including glioblastoma and melanoma. The trial is currently active but not …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Evaluation of the CONVIVO System [NA]
The CONVIVO System is currently recruiting for a clinical trial evaluating its use in brain tumor surgery. It targets glioblastoma, glioma, …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Imaging Acetadote Metabolism in Glioblastoma [EARLY_Phase 1]
A clinical trial update describes an early-phase 1 study imaging the metabolism of Acetadote (N-acetylcysteine) in glioblastoma; the trial i…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluates azeliragon in combination with chemoradiotherapy for newly diagnosed glioblastoma, sponsored by Cantex …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG) [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating a combination of ADI-PEG 20, temozolomide, and radiotherapy for newly diagnosed high-grade glioma, …
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: INtraoperative photoDYnamic Therapy of GliOblastoma [NA]
A completed clinical trial evaluating intraoperative photodynamic therapy for glioblastoma.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors [NA]
A pilot clinical trial at Michigan State University is evaluating a metabolic nutritional therapy for the management of glioblastoma, a prim…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: 5G-PEARL: Paxalisib in Malignant Brain Tumours [Phase 1, Phase 2]
This update describes a Phase 1/2 clinical trial (5G-PEARL) evaluating paxalisib in malignant brain tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency [Phase 1]
A Phase 1 pilot study evaluating the combination of navigated focused ultrasound and pembrolizumab for recurrent glioblastoma with mismatch …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
This entry provides an update on an ongoing clinical trial aimed at improving understanding of glioblastoma by preserving biologically activ…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma [Phase 2]
Phase 2 clinical trial evaluating simultaneous integrated boost using FDOPA PET guidance for glioblastoma in partially- or non-operated adul…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: CARv3-TEAM-E T Cells in Glioblastoma [Phase 1]
A Phase 1 clinical trial evaluating CARv3-TEAM-E T cells for glioblastoma and malignant glioma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma [Phase 1]
This is a Phase 1 clinical trial evaluating memory-enriched T cells for recurrent or refractory Grade III-IV glioma, including glioblastoma …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study [Phase 2]
A randomized Phase II trial is evaluating the use of PET-DOPA imaging to guide re-irradiation in patients with glioblastoma and is currently…
-
CLINICAL_TRIALS other · 2026-02-04Clinical Trial Update: TH-CAR-027 for Grade 4 Gliomas [EARLY_Phase 1]
Clinical trial update on TH-CAR-027 for recurrent/relapsed Grade 4 glioma. The study is in early Phase 1 and not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study [Phase 2]
Mayo Clinic sponsors a Phase 2 trial (SAGA) evaluating short-course radiotherapy for glioblastoma; the study is currently active but not rec…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma [Phase 1]
Phase 1 dose-finding trial of [177Lu]Lu-NeoB in newly diagnosed and recurrent glioblastoma; study status is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Surgery for Recurrent Glioblastoma [Phase 2]
A Phase 2 clinical trial assessing surgical treatment for recurrent glioblastoma is currently recruiting, sponsored by Insel Gruppe AG and U…